Tong Ren Tang Technologies Co Ltd
SWB:TNG
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
T
|
Tong Ren Tang Technologies Co Ltd
HKEX:1666
|
5.6B HKD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
978.7B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.3B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
277.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
210B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
220.8B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
273B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.6T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
150.2B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
95.7B EUR |
Loading...
|
Market Distribution
| Min | -409 046.1% |
| 30th Percentile | -1.4% |
| Median | 4.2% |
| 70th Percentile | 10.3% |
| Max | 876.4% |
Other Profitability Ratios
Tong Ren Tang Technologies Co Ltd
Glance View
Tong Ren Tang Technologies Co., Ltd. engages in the production and distribution of Chinese medicine. The company is headquartered in Beijing, Beijing. The company went IPO on 2000-10-31. The Company’s subsidiaries include Beijing Tong Ren Tang Technologies (Tangshan) Co., Ltd, Beijing Tong Ren Tang Century Advertising Co., Limited and Beijing Tong Ren Tang International Natural-Pharm Co., Ltd.. Through its subsidiaries, the Company is also engaged in cultivating, purchasing and selling Chinese medicinal raw materials.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Tong Ren Tang Technologies Co Ltd is 11.9%, which is below its 3-year median of 15%.
Over the last 3 years, Tong Ren Tang Technologies Co Ltd’s Operating Margin has decreased from 15.9% to 11.9%. During this period, it reached a low of 12.1% on Jun 30, 2025 and a high of 17.9% on Dec 31, 2022.
